Archive for May 2023
This heart will go on: Cambridge firm’s device enables ‘record-breaking’ transplant
Massachusetts General Hospital has implanted a heart that came from a donor in Juneau, Alaska — 2,884 miles away. Read More
Read MoreDesktop Metal to be acquired by 3D printer maker in $1.8B deal
The deal is one of the largest acquisitions involving a Bay State tech company so far in 2023. Read More
Read MoreBrett commentary: Tax code must be changed to drive N.E. innovation
Jim Brett writes, "The New England Council believes firmly that the new R&D amortization requirement will halt and harm our region’s continued growth and leadership on the global stage." Read More
Read MoreApellis stops pursuing ALS drug approval after trial failure
Apellis Pharmaceuticals Inc. is stopping work on a drug for amyotrophic lateral sclerosis, or ALS, after it failed in a midstage trial. Read More
Read MoreHere’s what it takes to be a food vendor at Boston Calling
It’s not only the music that is going to welcome thousands of people to Allston this weekend for Boston Calling. The food vendors, armed with extra napkins, are ready to feed the masses of hungry festival-goers. Read More
Read MoreEditorial: Plastic bans hurt local businesses. There are better options.
Reducing plastic waste is a worthy goal, but blanket bans that include no input from the businesses they’ll impact most are not the answer. Read More
Read MoreClub Quarters Boston hotel heading for foreclosure after loan negotiations stall
The owner, a Blackstone Group real estate fund, has been delinquent on the loan for 34 months. Read More
Read MoreLocal companies are trying to change how we recycle EV batteries
Electric vehicles are touted for their positive environmental impact, but are powered by internal batteries that require sky-high carbon emissions — and a lot of money — to be recycled. Read More
Read MoreThe Petri Dish: FDA delays Sarepta decision; Novartis buys Avrobio drug
The FDA has given itself a few more weeks to decide on the fate of Sarepta Therapeutics’ latest treatment for Duchenne muscular dystrophy. Read More
Read MoreThree local tech companies see stock gains after reports of possible sales
Rumors on a potential sale of Rapid7 Inc. emerged earlier this year. Now, two other publicly traded tech companies based in Massachusetts are reportedly looking for buyers. Read More
Read More